Literature DB >> 11414661

Involvement of adenosine in the effect of antidepressants on glutamate and aspartate release in the rat prefrontal cortex.

K Gołembiowska1, A Dziubina.   

Abstract

The effect of local administration of amitriptyline (AMI), desipramine (DMI) and citalopram (CIT) on veratridine-evoked glutamate (Glu) and aspartate (Asp) release in the prefrontal cortex of the conscious rat was examined using in vivo reverse microdialysis. The antidepressants (each at 100 microM) significantly reduced Glu and Asp release. The effect of AMI and CIT was attenuated by i.p. administration of the adenosine A1/A2A receptor antagonist caffeine (10 mg/kg), or by local infusion of the adenosine A1 receptor antagonist 8-cyclopentyltheophylline (CPT, 75 microM). Neither caffeine nor CPT influenced the effect of DMI (100 microM). The inhibitory action of DMI at a lower concentration (50 microM) was diminished significantly by CPT, but not caffeine. Perfusion of 5-hydroxytryptamine (5-HT; 100 microM) and the selective agonist of adenosine A1 receptors N6-cyclopentyladenosine (CPA; 50 and 100 microM) also suppressed Glu and Asp release. It is suggested that the blockade of the cellular uptake of adenosine, or indirect enhancement of its release, and subsequent activation of adenosine A1 receptors may be responsible for the inhibitory effect of antidepressants on Glu and Asp release.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11414661     DOI: 10.1007/s002100100421

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  3 in total

1.  Amitriptyline inhibits the activity of the rat glutamate transporter EAAT3 expressed in Xenopus oocytes.

Authors:  Hee-Jung Baik; Soon-Ae Lee; Jacqueline M Washington; Zhi-yi Zuo
Journal:  J Pharm Pharmacol       Date:  2009-05       Impact factor: 3.765

Review 2.  Modulation of NMDA Receptor Activity in Fibromyalgia.

Authors:  Geoffrey Littlejohn; Emma Guymer
Journal:  Biomedicines       Date:  2017-04-11

3.  Potential antipsychotic action of the selective agonist of adenosine A1 receptors, 5'-Cl-5'-deoxy-ENBA, in amphetamine and MK-801 rat models.

Authors:  Krystyna Ossowska; Barbara Kosmowska; Jadwiga Wardas
Journal:  Pharmacol Rep       Date:  2020-03-26       Impact factor: 3.024

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.